(ISSN: 0950-222X, 1476-5454)
Table of Contents
2016 - 30 (6)
- Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
- The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sj��gren's syndrome: a pilot study.
- Comment on 'The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary'.
- Finasteride is effective for the treatment of central serous chorioretinopathy.
- Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss?
- Development and validation of a Bayesian network for the differential diagnosis of anterior uveitis.
- Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma.
- Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma.
- Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus.
- Prevalence of reticular pseudodrusen in newly presenting adult onset foveomacular vitelliform dystrophy.
- Optical coherence tomography angiography in paracentral acute middle maculopathy secondary to central retinal vein occlusion.
- The accuracy of the Edinburgh diplopia diagnostic algorithm.
- Introduction to metabolomics and its applications in ophthalmology.
- Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.
- Prevalence and associated factors of myopia among primary and middle school-aged students: a school-based study in Guangzhou.
- Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
- Comment on: 'Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab'.
- Comment on: 'Effectiveness of a smartphone application for testing near visual acuity'.
- Intravitreal aflibercept for choroidal neovascularisation in angioid streaks.
- Reply to 'Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab'.
- Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.
- Comment on: 'Effectiveness of a smartphone application for testing near-visual acuity'.